These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16478896)

  • 1. Beta2-adrenergic receptor genotype and survival after acute coronary syndrome.
    Jackson CM; Lipworth BJ
    JAMA; 2006 Feb; 295(7):757; author reply 757-8. PubMed ID: 16478896
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta2-adrenergic receptor genotype and survival after acute coronary syndrome.
    Snyder EM; Johnson BD
    JAMA; 2006 Feb; 295(7):756-7; author reply 757-8. PubMed ID: 16478895
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
    Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
    JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
    Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
    J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-adrenergic receptor genotype predicts survival: implications and future directions.
    Lanfear DE; Spertus JA; McLeod HL
    J Cardiovasc Nurs; 2006; 21(6):474-7. PubMed ID: 17293738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of acute coronary syndromes.
    Hughes K
    Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine and metoprolol in suspected unstable angina. Review of other trials.
    Eur Heart J; 1987 Oct; 8 Suppl H():87-98. PubMed ID: 2895710
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
    Snapir A; Koskenvuo J; Toikka J; Orho-Melander M; Hinkka S; Saraste M; Hartiala J; Scheinin M
    Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of acute myocardial infarction and unstable coronary syndrome].
    Gjesdal K; Aursnes I
    Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2774-7. PubMed ID: 1977206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor blockade in the treatment of coronary heart disease.
    Sleight P
    Eur Heart J; 1986 Dec; 7 Suppl C():79-91. PubMed ID: 2880717
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups.
    Mukherjee D; Fang J; Kline-Rogers E; Otten R; Eagle KA
    Heart; 2005 Mar; 91(3):381-2. PubMed ID: 15710731
    [No Abstract]   [Full Text] [Related]  

  • 13. The angiotensin converting enzyme genetic polymorphism in acute coronary syndrome--ACE polymorphism as a risk factor of acute coronary syndrome.
    Park HY; Kwon HM; Kim D; Jang Y; Shim WH; Cho SY; Kim HS
    J Korean Med Sci; 1997 Oct; 12(5):391-7. PubMed ID: 9364295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of beta2-adrenergic receptor polymorphisms.
    Bartels NK; Börgel J; Wieczorek S; Büchner N; Hanefeld C; Bulut D; Mügge A; Rump LC; Sanner BM; Epplen JT
    BMC Med; 2007 Jan; 5():1. PubMed ID: 17198546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective relief of acute coronary syndrome.
    Castle N
    Emerg Nurse; 2003 Feb; 10(9):15-9. PubMed ID: 12655961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms?
    Vriz O; Minisini R; Zito C; Boccato E; Fimiani F; Pirisi M; Facciolo C; Limongelli G; Bossone E; Calabrò P
    Int J Cardiol; 2015 Nov; 199():189-92. PubMed ID: 26197406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of acute coronary syndrome. Summary of a hearing arranged by the Norwegian Cardiologic Society and the Institute of pharmacotherapy].
    Aursnes I; Osnes JB; Platou ES; Smiseth OA; Amlie JP
    Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2788-90. PubMed ID: 1977207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association studies; the good, the bad, and the ugly.
    Donahue MP; Kraus WE
    Am Heart J; 2007 Oct; 154(4):610-2. PubMed ID: 17892978
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.